Literature DB >> 27919405

Merkel Cell Carcinoma: An Update of Key Imaging Techniques, Prognostic Factors, Treatment, and Follow-up.

B Llombart1, S Kindem2, M Chust3.   

Abstract

Merkel cell carcinoma, though rare, is one of the most aggressive tumors a dermatologist faces. More than a third of patients with this diagnosis die from the disease. Numerous researchers have attempted to identify clinical and pathologic predictors to guide prognosis, but their studies have produced inconsistent results. Because the incidence of Merkel cell carcinoma is low and it appears in patients of advanced age, prospective studies have not been done and no clear treatment algorithm has been developed. This review aims to provide an exhaustive, up-to-date account of Merkel cell carcinoma for the dermatologist. We describe prognostic factors and the imaging techniques that are most appropriate for evaluating disease spread. We also discuss current debates on treating Merkel cell carcinoma.
Copyright © 2016 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Carcinoma de células de Merkel; Chemotherapy; Factores pronóstico; Follow-up; Ganglio centinela; Merkel cell carcinoma; Prognosis; Quimioterapia; Radioterapia; Radiotherapy; Seguimiento; Sentinel lymph node; Surgery; Tratamiento quirúrgico

Mesh:

Substances:

Year:  2016        PMID: 27919405     DOI: 10.1016/j.ad.2016.07.021

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  10 in total

1.  [Merkel cell carcinoma].

Authors:  Christina Drusio; Jürgen C Becker; Dirk Schadendorf; Selma Ugurel
Journal:  Hautarzt       Date:  2019-03       Impact factor: 0.751

Review 2.  Importance of studying primitive neuroectodermal tumors and extraosseous Ewings sarcoma of the vagina and vulva.

Authors:  Adeline Tintila; Bogdan Doroftei; Delia Grab; Gabriela Simionescu; Emil Anton; Radu Maftei; Ciprian Ilea; Carmen Anton
Journal:  Oncol Lett       Date:  2021-01-04       Impact factor: 2.967

Review 3.  Merkel cell carcinoma.

Authors:  K Mistry; N J Levell; P Craig; N M Steven; Z C Venables
Journal:  Skin Health Dis       Date:  2021-06-16

4.  Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel.

Authors:  Francesca Spada; Paolo Bossi; Corrado Caracò; Vanna Chiarion Sileni; Angelo Paolo Dei Tos; Nicola Fazio; Giovanni Grignani; Michele Maio; Pietro Quaglino; Paola Queirolo; Paolo Antonio Ascierto
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

Review 5.  Merkel cell carcinoma.

Authors:  Jürgen C Becker; Andreas Stang; James A DeCaprio; Lorenzo Cerroni; Celeste Lebbé; Michael Veness; Paul Nghiem
Journal:  Nat Rev Dis Primers       Date:  2017-10-26       Impact factor: 52.329

6.  A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients.

Authors:  Marco Rastrelli; Paolo Del Fiore; Alessandra Buja; Antonella Vecchiato; Carlo Riccardo Rossi; Vanna Chiarion Sileni; Saveria Tropea; Francesco Russano; Manuel Zorzi; Romina Spina; Rocco Cappellesso; Renzo Mazzarotto; Francesco Cavallin; Franco Bassetto; Elisabetta Bezzon; Beatrice Ferrazzi; Mauro Alaibac; Simone Mocellin
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

7.  Clinical Features and Prognosis of Merkel Cell Carcinoma in Elderly Patients.

Authors:  YiJun Xia; DongSheng Cao; Jun Zhao; BangZhong Zhu; Juan Xie
Journal:  Med Sci Monit       Date:  2020-07-12

8.  Primary Merkel cell carcinoma of the earlobe in a young healthy man.

Authors:  Non Hyeon Ha; Sue Kyung Kim; Yoo Seob Shin; Sue Min Kim
Journal:  Arch Craniofac Surg       Date:  2018-09-20

Review 9.  Burden of Disease, Early Diagnosis, and Treatment of Merkel Cell Carcinoma in Latin America.

Authors:  Rafael A Schmerling; Jose G Casas; Gabriela Cinat; Fabio Ernesto Grosso Ospina; Luiza E B P Kassuga; Jorge Luis Martinez Tlahuel; Luis Daniel Mazzuoccolo
Journal:  J Glob Oncol       Date:  2018-07

10.  18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study.

Authors:  Silvia Taralli; Martina Sollini; Michele Milella; Germano Perotti; Angelina Filice; Massimo Menga; Annibale Versari; Vittoria Rufini
Journal:  EJNMMI Res       Date:  2018-07-21       Impact factor: 3.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.